CLINICAL_TRIALS ClinicalTrials.gov record update

An Open-Label Phase 2 Study of Surufatinib in Patients With Neuroendocrine Tumours in Europe

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT04579679
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-25T22:27:32.885794+00:00
Published At: 2025-07-25T00:00:00+00:00
Record Updated At: 2025-07-25
Results Posted At: 2025-07-25
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Neuroendocrine Tumours", "Neuroendocrine Tumour of the Lung", "Small Intestinal NET"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2025-07-25"
protocolSection.identificationModule.nctId: "NCT04579679"
protocolSection.identificationModule.officialTitle: "An Open-Label Phase 2 Study of Surufatinib in Patients With Neuroendocrine Tumours in Europe"
protocolSection.statusModule.overallStatus: "TERMINATED"
protocolSection.designModule.phases: ["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2025-07-25"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.